Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	667.05	365.91	263.31	280.12	410.48
Short-Term Investments	1,650	-	19.96	34.98	225.67
Cash & Short-Term Investments	2,317	365.91	283.27	315.09	636.16
Cash Growth	533.18%	29.18%	-10.10%	-50.47%	15.66%
Accounts Receivable	376.37	153.48	7.79	21.64	20.5
Other Receivables	16.2	8.02	7.62	6.08	4.83
Receivables	392.57	161.51	15.4	27.72	25.33
Prepaid Expenses	1.81	2.42	2.33	22.38	44.34
Other Current Assets	3.64	63.02	13.34	43.7	2.51
Total Current Assets	2,715	592.86	314.33	408.9	708.33
Property, Plant & Equipment	21.03	43.04	41.83	44.78	54.49
Long-Term Investments	61.86	-	-	-	-
Goodwill	34.95	34.95	34.95	34.95	34.95
Other Intangible Assets	0.59	1.07	1.31	-	4.5
Long-Term Deferred Tax Assets	202.85	117.23	105.18	91.08	53.08
Other Long-Term Assets	1.04	1.43	0.93	2.73	21.11
Total Assets	3,037	790.56	498.53	582.44	876.46
Accounts Payable	13.97	6.22	1.08	9.36	14.09
Accrued Expenses	52.18	18.53	14.61	17.59	16.97
Current Portion of Leases	5.57	10.14	6.2	7.82	8.13
Current Income Taxes Payable	124.76	1.34	0.01	0.01	0.04
Other Current Liabilities	13.01	9.13	7.84	3.12	3.17
Total Current Liabilities	209.49	45.35	29.73	37.9	42.4
Long-Term Leases	7.67	19.46	5.7	5.54	12.17
Long-Term Unearned Revenue	39.43	-	-	-	-
Long-Term Deferred Tax Liabilities	23.81	4.63	-	-	0.29
Other Long-Term Liabilities	0.49	-	-	-	-
Total Liabilities	280.88	69.44	35.43	43.44	54.86
Common Stock	1,411	1,302	1,221	1,157	1,156
Additional Paid-In Capital	1,253	579.02	338.41	231.74	229.73
Retained Earnings	215.2	-1,089	-1,049	-801	-518.9
Comprehensive Income & Other	-123.18	-70.76	-47.93	-48.76	-44.88
Shareholders' Equity	2,756	721.12	463.1	539	821.6
Total Liabilities & Equity	3,037	790.56	498.53	582.44	876.46
Total Debt	13.24	29.59	11.89	13.36	20.3
Net Cash (Debt)	2,304	336.32	271.38	301.73	615.86
Net Cash Growth	584.95%	23.93%	-10.06%	-51.01%	12.48%
Net Cash Per Share	17.10	2.68	2.31	2.61	5.61
Filing Date Shares Outstanding	141.09	130.16	122.13	115.7	115.57
Total Common Shares Outstanding	141.09	130.16	122.13	115.7	115.57
Working Capital	2,505	547.5	284.61	371	665.93
Book Value Per Share	19.54	5.54	3.79	4.66	7.11
Tangible Book Value	2,721	685.11	426.85	504.05	782.16
Tangible Book Value Per Share	19.28	5.26	3.50	4.36	6.77
Machinery	55.98	66.98	76.07	70.51	65.67
Leasehold Improvements	12.64	15.54	15.49	15.79	15.76

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.